Keywords: fda, reviews, novartis, gsk, asthma, drugs, food

FDA reviews Novartis and GSK asthma drugs

Article | 18 July 2005

Print This

The US Food and Drug Administration is planning a safety review of the salmeterol-based asthma drugs Serevent and Advair, marketed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in